Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-20 9:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
7,583 | $47.89 | $363,142 | 79,682 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 7:03 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
4,879 | $30.6 | $149,297 | 99,405 (Direct) |
View |
| 2023-03-21 Sale |
2023-03-23 7:56 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
1,141 | $12.55 | $14,324 | 54,696 (Direct) |
View |
| 2023-03-17 Sale |
2023-03-21 7:12 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
740 | $12.94 | $9,573 | 55,837 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-17 6:15 pm |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
357 | $13.43 | $4,795 | 71,868 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-15 Exercise |
2025-03-18 9:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
42,528 | $0 | 132,718 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:19 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
50,717 | $0 | 50,717 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-19 7:03 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
26,490 | $0 | 99,405 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 5:10 pm |
N/A 2034-03-06 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
79,579 | $0 | 79,579 (Direct) |
View |
| 2023-03-15 Exercise |
2023-03-17 6:15 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
5,097 | $0 | 71,868 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:26 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
80,708 | $0 | 80,708 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:17 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
89,886 | $0 | 89,886 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-08 4:57 pm |
N/A 2031-01-06 |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
61,499 | $0 | 61,499 (Direct) |
View |
Ownership |
2020-10-15 8:11 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
0 | $0 | 276,749 (Direct) |
View |